Pfizer buy Array BioPharma for $11.4 billion

June 18, 2019
Manufacturing and Production

Pfizer has said it will acquire Colorado-based cancer specialist Array BioPharma for $11.4 billion. Pfizer has announced that it has …

Boehringer Ingelheim open new plant in Catalonia

June 17, 2019
Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallรจs near Barcelona. The new …

facilities_lg06

Dr Reddy’s sells of two migraine treatments to Upsher-Smith Laboratories in deal worth $110 million

June 17, 2019
Sales and Marketing

Indian firm Dr Reddyโ€™s has agreed to sell two migraine treatments to American firm Upsher-Smith Laboratories in a deal worth …

image_credit_united_states_mission_geneva

WHO decide not to declare global emergency

June 17, 2019
Sales and Marketing Ebola, UN, WHO, global emergency, health, pharma

The WHO has decided not to declare the Ebola crisis in the Congo a global emergency. While the WHO said …

29496564944_a9faceb1c2_z

Drugmakers sue Trump over prices in TV ads

June 17, 2019
Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …

16578744517_ed4293d3e7_z

Patient dies after receiving faecal transplant

June 17, 2019
Sales and Marketing Adverse Event, E.Coli. AMR, FDA, faecal transplant, pharma

A person has died after experiencing an adverse event related to a faecal transplant. The FDA has warned that two …

millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

June 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …

gilead_hq_at_stockley_park_london_2

Gilead inks deal with Canadian antibody discovery firm AbCellera

June 14, 2019
Medical Communications AbCellera, Gilead, monoclonal antibodies, pharma

Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimerโ€™s. This was the big revelation this week! …

merckincweb2

FDA ask MSD to join blockchain supply chain network

June 14, 2019
Medical Communications FDA, MSD, Merck, blockchain, supply chain

The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and …

teva_copy

Teva recall heart drug after carcinogen found in API

June 14, 2019
Medical Communications API, Contamination, NMDA, Teva, carcinogen, pharma, recall

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient …

800px-uc-berkeley-campus-overview-from-hills

GSK sets up new CRISPR lab with UC, Berkeley

June 13, 2019
Medical Communications GSK, UC, berkely, crispr, genetics, pharma

GSK has struck a $67 million deal with the University of California, Berkeley. British multinational GlaxoSmithKline will collaborate with UC, …

dr_aiden_cottrell

GSK tech exec joins Institute of Cancer Research

June 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Institute of Cancer Research (ICR) has said GlaxoSmithKlineโ€™s Dr Adrian Cottrell will join as the instituteโ€™s new Chief Information …

5204602349_c87b204860_z

Catalyst Pharma sues FDA after agency approves Jacobus’ LEMS drug

June 13, 2019
Business Services, Manufacturing and Production FDA, Jacobus, catalyst, firdapse, pharma, ruzurgi

Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rivalโ€™s drug. The lawsuit alleges the approval …

genentech_web

FDA offer priority review for Genentech’s Rituxan in children

June 13, 2019
Research and Development

The FDA will offer priority review to Genentechโ€™s supplemental biologics-license application (sBLA) application for Rituxan for children with two rare …

sobi_offices

Sobi acquire Novimmune in deal worth more than ยฃ400 million

June 13, 2019
Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma

Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than ยฃ400 million. …

J&J and Colgate pay $4.8 million each to woman in California

June 13, 2019
Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc

A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …

cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZenecaโ€™s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of ยฃ330 million that …

Fewer opioids prescribed in states with medical marijuana, research shows

June 12, 2019
Research and Development Marijuana, medicinal cannabis, opioids, pharma

Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …

J&J ‘worse’ than Purdue Pharma expert witness says

June 12, 2019
Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra

The role Johnson & Johnson played in the opioid crisis was โ€˜in some ways worseโ€™ than that of Purdue Pharma, …

The Gateway to Local Adoption Series

Latest content